A Commitment to Excellence

Jefferson Scholars Foundation | Campaign Impact

 

 

The Jefferson Scholars Foundation has remained steadfast in its mission to identify and attract exceptionally talented leaders, scholars, and citizens.

During the Honor the Future Campaign, the foundation underscored its commitment to this ideal, while aligning its philanthropic priorities with the evolving needs of the University.

 

With your help we’ve raised

0 from 0 donors


Campaign Highlights
Tremendous and transformative alumni support
Campaign Highlights

In addition to the $284,126,161 campaign total, more than $45 million was raised by the Jefferson Scholars Foundation in collaboration with the College and Graduate School of Arts & Sciences, the Darden School, and the School of Engineering and Applied Science.

A defining moment of the campaign came in 2019 with a $100 million commitment from Jane and David Walentas. Their transformative investment included $50 million to launch a first-of-its-kind, merit-based scholarship for first-generation, college-bound students. What began as an effort to attract outstanding students from Virginia and New York has expanded into a national program. With additional support from UVA alumni, matched by the University’s Strategic Investment Fund, the Walentas Scholars Program now draws nominees from 19 regions, including Atlanta, Boston, Chicago, Los Angeles, Maryland, and St. Louis. Next year, for the first time, 60 Walentas Scholars across four cohorts will be on Grounds. The program’s inaugural class will graduate in 2026, leaving its mark on UVA through student leadership, academic achievement, and service to the broader community.

Equally transformative was the expansion of the foundation’s Distinguished Professorship Program. Through the extraordinary generosity of its benefactors, matched by UVA’s Bicentennial Professors Fund, the foundation secured approximately $144 million, increasing its total faculty endowment to $218 million. Among the new professorships created, eight carry the prestigious designation of University Professor—UVA’s highest faculty honor. These cross-disciplinary appointments, each endowed at the $10 million level, serve as vital instruments in attracting scholars of international distinction and influence.

The foundation’s flagship Jefferson Scholars Program continued to thrive during the campaign. More than 50 new scholarships were created, further strengthening a program that has invested over $163 million in direct support since its founding. Jefferson Scholars consistently lead the student body—in academics, service, and citizenship. Their impact is felt across Grounds and beyond.

The foundation’s recruiting influence extends well beyond the holders of its scholarships. Each year, hundreds of highly qualified Jefferson and Walentas Scholar nominees choose to enroll at UVA after participating in the selection process. In 2025-26, 468 nominees will join the Class of 2029—or 12 percent of the class. In response to the growing pipeline of top students, the foundation launched a loan replacement initiative to support finalists who were not selected for a full scholarship but were offered federal loans as part of their aid packages. This strategic investment not only eases the financial burden for these students but also positions UVA as a destination for students who are weighing offers from peer institutions. To date, the foundation has secured nearly $10 million in total funding for Loan Replacement Grants, which offers up to $28,000 over four years for out-of-state students and up to $18,000 over four years for in-state students.

Saunders Family Creates Inaugural Endowed University Professorships

 

The family of Thomas A. Saunders III established the first-ever fully endowed University Professorships with a $10 million commitment to the foundation, matched by UVA’s Bicentennial Professors Fund for a total investment of $20 million. Their generosity allowed the University to attract two eminent scientists.

Headshot

“The Manning Institute represents an unprecedented opportunity both for me, personally, and for the entire field of healthcare.”

Mark Esser (Med ’98)
Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor
Chief Scientific Officer and Head of the Manning Institute

Mark Esser, former vice president at the global biopharmaceutical company AstraZeneca, was appointed the Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor in 2025. At UVA, Esser serves as the inaugural director of the new Paul and Diane Manning Institute of Biotechnology, where he guides ambitious efforts to accelerate the translation of groundbreaking scientific discoveries into therapies and medicines that improve human health.

A distinguished scientist and accomplished executive, Esser comes to UVA with nearly 30 years of experience in biomedical research and drug development. At AstraZeneca, he oversaw antibody and vaccine discovery, research, and translational medicine for the company’s infectious disease programs, helping shepherd early-stage science from concept to clinical application.

Esser holds more than 100 peer-reviewed research and clinical publications, five patents, and has contributed to more than 20 different drug and vaccine discovery and development programs drugs. Among his most notable achievements are contributing to the development of Gardasil, the HPV vaccine that prevents cervical cancer, and Beyfortus, a monoclonol antibody that protects against respiratory syncytial virus (RSV). Beyfortus was unanimously approved by the U.S. Food and Drug Administration in 2023.

Headshot

“As a scientist, I couldn’t turn down this rare opportunity.”

Evan Scott
Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor

Evan A. Scott, a preeminent scholar in biomedical engineering, joined the faculty in 2024 as the Thomas A. Saunders III Family Jefferson Scholars Foundation Distinguished University Professor. Renowned for his pioneering work utilizing nanotechnology to combat cancer, glaucoma, and heart disease, among other diseases and ailments, Scott leads UVA’s Institute for Nanoscale Scientific and Technological Advanced Research, or nanoSTAR.

Scott brings to UVA more than a decade of experience teaching and spearheading groundbreaking research at Northwestern University. With over 80 publications, 21 patents, and nearly 30 career-affirming awards, including the National Science Foundation CAREER Award, the Nano Research Young Innovator Award in Nanobiotechnology, the Biomedical Engineering Society Mid-Career Award, the BMES Young Innovator of Cellular and Molecular Bioengineering, Scott brings a wealth of expertise and scholarly recognition to UVA. His work, which has been generously funded by the National Institutes of Health (NIH), applies principles from biomaterials science, nanotechnology, and tissue engineering towards the development of translational immunotherapies.

At UVA, Scott holds dual appointments in the School of Medicine and the School of Engineering and Applied Science. In addition, he supports UVA’s Cancer Center and works to foster interdisciplinary collaborations across Grounds.

The Jefferson Scholars Foundation’s achievements over the course of the campaign are more than milestones; they are enduring expressions of what is possible when a community rallies around an unwavering commitment to excellence. The foundation does not merely support individuals, it identifies catalysts for progress, invests in their potential, and positions them to shape the University and the world beyond. We remain deeply grateful to those who share in our belief that the future of the University will be written by the individuals we invest in today.